Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients

被引：4
|
作者：
Derijks, L. J. J. [1 ]
van Helden, R. B. [2 ]
Hommes, D. W. [2 ]
Stokkers, P. C. [3 ]
机构：
[1] Maxima Med Ctr, Dept Clin Pharm, NL-5500 MB Veldhoven, Netherlands
[2] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
来源：
GUT | 2008年 / 57卷 / 06期
关键词：
D O I：
10.1136/gut.2007.145912
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：872 / 872
页数：1
相关论文
共 50 条
  • [31] Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease
    Pashazadeh, Paria
    Marjani, Abdoljalal
    Asadi, Jahanbakhash
    Khoshnia, Masoud
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (04) : 541 - 547
  • [32] Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine
    Zhu Qin
    Cao Qian
    [J]. CHINESE MEDICAL JOURNAL, 2012, 125 (20) : 3665 - 3670
  • [33] Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low dose azathioprine
    Campbell, S
    Kingstone, K
    Ghosh, S
    [J]. GUT, 2002, 50 : A14 - A14
  • [34] Thiopurine methyltransferase activity and adverse effects of azathioprine in at risk paediatric inflammatory bowel disease patients
    Parry, Christopher
    Hawcutt, Daniel
    Krishnamurthy, Srividyadhari
    Renji, Elizabeth
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1622 - 1622
  • [35] Efficacy, tolerance of azathioprine and pharmacogenetics of thiopurine methyltransferase in pediatric inflammatory bowel disease
    Zhang, D.
    Languepin, J.
    Medard, Y.
    Cezard, J. P.
    Jacqz-Aigrain, E.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 38 - 38
  • [36] Thiopurine Methyltransferase Activity Influences Clinical Response to Azathioprine in Inflammatory Bowel Disease
    Cuffari, Carmen
    Dassopoulos, Themistocles
    Turnbough, Lisa
    Thompson, Richard E.
    Bayless, Theodore M.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (05) : 410 - 417
  • [37] Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
    Colombel, JF
    Ferrari, N
    Debuysere, H
    Marteau, P
    Gendre, JP
    Bonaz, B
    Soulé, JC
    Modgliani, R
    Touze, Y
    Catala, P
    Libersa, C
    Broly, F
    [J]. GASTROENTEROLOGY, 2000, 118 (06) : 1025 - 1030
  • [38] Plasma thiopurine S-methyltransferase levels and azathioprine-related adverse events in patients with Behcet's disease
    Emmungil, H.
    Durusoy, R.
    Kalfa, M.
    Zihni, F. Yargucu
    Ozmen, M.
    Keser, G.
    Guecenmez, S.
    Yilmaz, Z.
    Aksu, K.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (06) : S40 - S45
  • [39] Study of the concordance between the enzymatic activity of Thiopurine S-methyltransferase and polymorphisms in the TPMT gene in patients with Inflammatory Bowel Disease
    Cespedes Martinez, E.
    Robles-Alonso, V.
    Castellote, L.
    Bravo-Nieto, D.
    Serra, X.
    Herrera-De Guise, C.
    Mayorga, L.
    Perez, Z.
    Oller, E.
    Garriga-Edo, S.
    Casellas, F.
    Borruel, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1480 - I1481
  • [40] Unexplained higher frequency of mutant thiopurine S-methyltransferase genotypes in inflammatory bowel disease patients of Latvia population.
    Zalizko, P.
    Stefanovics, J.
    Erts, R.
    Rovite, V.
    Klovins, J.
    Pukitis, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S537 - S537
12345